1. Home
  2. LARK vs TNYA Comparison

LARK vs TNYA Comparison

Compare LARK & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Landmark Bancorp Inc.

LARK

Landmark Bancorp Inc.

SELL

Current Price

$32.30

Market Cap

190.1M

Sector

Finance

ML Signal

SELL

Logo Tenaya Therapeutics Inc.

TNYA

Tenaya Therapeutics Inc.

N/A

Current Price

$0.35

Market Cap

153.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LARK
TNYA
Founded
1885
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
190.1M
153.2M
IPO Year
2001
2021

Fundamental Metrics

Financial Performance
Metric
LARK
TNYA
Price
$32.30
$0.35
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $3.67
AVG Volume (30 Days)
4.6K
★ 3.5M
Earning Date
10-28-2026
11-04-2026
Dividend Yield
★ 2.60%
N/A
EPS Growth
35.84
★ 54.96
EPS
★ 2.59
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.48
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.57
$0.30
52 Week High
$34.60
$1.46

Technical Indicators

Market Signals
Indicator
LARK
TNYA
Relative Strength Index (RSI) 54.47 35.17
Support Level $30.92 $0.30
Resistance Level $32.40 $0.43
Average True Range (ATR) 0.43 0.03
MACD 0.02 0.01
Stochastic Oscillator 53.56 36.12

Price Performance

Historical Comparison
LARK
TNYA

About LARK Landmark Bancorp Inc.

Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The Bank has continued to focus on increasing its originations of commercial, commercial real estate (CRE), and agricultural loans, which management believes will be more profitable and provide more growth for the Bank than traditional one-to-four-family residential real estate lending. In addition, it also invests in certain investment and mortgage-related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and Southwest Kansas.

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

Share on Social Networks: